cannabinol


Also found in: Dictionary, Encyclopedia, Wikipedia.

cannabinol

 [kah-nab´ĭ-nol]
a physiologically inactive principle from Cannabis; its tetrahydro derivative (tetrahydrocannabinol) is active.

can·na·bi·nol

(ka-nab'i-nol),
A constituent of the resinous exudate of the pistillate flowers of Cannabis sativa; it has no psychotomimetic action as do the tetrahydro derivatives isolated from marijuana.
References in periodicals archive ?
(10.) Moore C, Rana S, Coulter C Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid.
See also l DAVID EVANS, DRUG TESTING LAW, TECHNOLOGY & PRACTICE [section] 1:19 (West 2017) (noting "[m]arijuana contains 500 chemicals including over 100 compounds called cannabinoids, including cannabinol, cannabidiol, cannabinolidic acids, cannabigerol, cannabichromene, and several isomers of tetrahydrocannabinol (THC)").
The plant contains toxins; the most important ones of them are tetrahydrocannabinol, cannabidiol, and cannabinol. This is why it belongs to the category of toxic plants of therapeutic interest.
The signals were optimized using a source block temperature of 500[degrees]C and an on-spray in the determination of [[DELTA].sup.9]-tetrahydrocannabinol, cannabidiol, and cannabinol in 50 mg of 179 hair samples.
Cayman Chemical's Phytocannabinoid Mixture 10 (CRM) is a quantitative, multi-analyte mixture for use as an analytical standard in the simultaneous detection of the 10 most prevalent phytocannabinoids found in cannabis plants: cannabidivarin (CBDV), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), cannabigerol (CBG), cannabidiol (CBD), cannabinol (CBN), tetrahydrocannabinolic acid A (THCA-A), [DELTA]9-tetrahydrocannabinol ([DELTA]9-THC), [DELTA]8-tetrahydrocannabinol ([DELTA]8-THC), and ([+ or -])-cannabichromene (CBC).
Among the other cannabinoids, the most studied ones are dronabinol (DBN) and nabilone, followed by cannabinol (CBN), cannabidiol (CBD), which seems to possess some anti-inflammatory, analgesic (Hohmann & Suplita, 2006; Rea, Roche & Finn, 2007; Jhaveri et al, 2008), anti-schemic (Lamontagne et al, 2006), antipsychotic (Leweke, Koethe & Gerth, 2005), ansiolitic (Crippa et al, 2011), and anti-epileptic effects (Mortati, Dworetzky & Devinsky, 2007); and finally, cannabigerol (CBG) and cannabicromeno (CBC) (Barceloux, 2012), which possess some properties which have been studied mainly in preclinical or animal models.
Currently, in Virginia, medical patients are able to use cannabinol to treat certain conditions after a bill was passed in 2016.
The research component of this special report is highly significant and a crucial contribution to the field, as it is designed to fill 2 voids: to compare blood and oral fluid THC, CBD, cannabinol (CBN), and metabolite concentrations following ingestion of edibles laced with cannabinoids; and to compare roadside testing devices that monitor oral fluids for cannabinoids with standard analytical techniques (LC-MS/MS), following consumption of cannabinoid edibles.
Furthermore, CYP2C9 inhibition was demonstrated in-vitro for THC, CBD and cannabinol (CBN) in Cannabis smoke.
Hemp Teaf: tetra hydro Retentive, cannabinol Oil: rich in anesthetic, proteins and vitamins astringent, sedative.